Comparing Costs Per Clinical Remission of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Patients with Rheumatoid Arthritis- A Brazilian Private Perspective
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.2216
https://www.valueinhealthjournal.com/article/S1098-3015(13)04128-4/fulltext
Title :
Comparing Costs Per Clinical Remission of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Patients with Rheumatoid Arthritis- A Brazilian Private Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)04128-4&doi=10.1016/j.jval.2013.08.2216
First page :
A716
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2032